CytomX Therapeutics Inc (CTMX) — Working Capital to Net Assets Ratio
CytomX Therapeutics Inc (CTMX) has a Working Capital to Net Assets ratio of 110.3% as of June 2026. Working capital of $333.29 Million (current assets of $373.15 Million minus current liabilities of $39.86 Million) is measured against net assets of $302.07 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CytomX Therapeutics Inc Working Capital to Net Assets (2013–2025)
This chart shows how CytomX Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 110.3%, reflecting working capital of $333.29 Million against net assets of $302.07 Million USD. Explore CytomX Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for CytomX Therapeutics Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CytomX Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CytomX Therapeutics Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.3% | $97.31 Million | $99.01 Million | $143.92 Million | $46.62 Million | ▲ +4820.4 pp |
| 2024 | -4722.1% | $21.53 Million | $-456.00K | $107.31 Million | $85.77 Million | ▼ -4665.2 pp |
| 2023 | -57.0% | $27.02 Million | $-47.45 Million | $182.94 Million | $155.91 Million | ▲ +41.6 pp |
| 2022 | -98.5% | $84.49 Million | $-85.75 Million | $237.10 Million | $152.61 Million | ▼ -326.8 pp |
| 2021 | 228.2% | $203.99 Million | $89.38 Million | $310.30 Million | $106.32 Million | ▲ +3520.0 pp |
| 2020 | -3291.8% | $255.90 Million | $-7.77 Million | $324.01 Million | $68.11 Million | ▼ -3717.8 pp |
| 2019 | 426.0% | $217.75 Million | $51.11 Million | $303.33 Million | $85.59 Million | ▲ +160.5 pp |
| 2018 | 265.6% | $347.57 Million | $130.88 Million | $445.48 Million | $97.91 Million | ▼ -202.9 pp |
| 2017 | 468.5% | $327.45 Million | $69.90 Million | $388.60 Million | $61.15 Million | ▲ +274.3 pp |
| 2016 | 194.2% | $152.38 Million | $78.48 Million | $188.15 Million | $35.77 Million | ▲ +56.1 pp |
| 2015 | 138.0% | $174.01 Million | $126.07 Million | $189.75 Million | $15.74 Million | ▲ +208.9 pp |
| 2014 | -70.9% | $55.69 Million | $-78.54 Million | $66.85 Million | $11.16 Million | ▼ -59.4 pp |
| 2013 | -11.5% | $5.09 Million | $-44.28 Million | $9.27 Million | $4.17 Million | — |